About
Pressroom
Resources
Get Updates
Issues
Access to Medicines
Funding the Fight
Health Justice
Transparency & Accountability
PEPFAR Watch
Blog
Our Impact
Take Action
Do something now
DONATE
Pfizer faces criticism for arguing that intellectual property for its Covid-19 pill is a human right
April 21, 2022 |
Jessica Bassett
Covid Booster Costs Spur Calls to Shift From Free Jabs for All
A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO
Related Posts
Access to Medicines
Pharma’s alleged “brea...
PEPFAR Watch
PEPFAR is Rolling the Cloc...
Access to Medicines
Pharma Pricing Secrecy Run...